CG oncology (CGON.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec22

LifeSci Capital Maintains Buy Rating on CG Oncology with a Price Target of $90

18:46

Dec9

JonesTrading Reiterates Buy Rating on CG Oncology Stock

14:17

Dec5

CG Oncology Announces Positive Results for Cretostimogene's Clinical Trials in High-risk Bladder Cancer

13:30

Nov25

CG Oncology to Present New Clinical Results for High-Risk Bladder Cancer at SUO Annual Meeting

21:05

Nov18

Guggenheim Analyst Reiterates Buy Rating on CG Oncology

12:08

Nov15

CG Oncology released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 1.666 M (forecast USD 72.56 K), actual EPS USD -0.5709 (forecast USD -0.5647)

04:00

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.666 M, Net Income -43.81 M, EPS -0.5709

Aug8

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -41.43 M, EPS -0.5434

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 52 K, Net Income -34.45 M, EPS -0.4521

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change